AZ, Sanofi-Aventis, Novo Nordisk fund online diabetes tool

The American Diabetes Association has launched a free, interactive diabetes risk assessment and management tool on its Web site, the organization reports. The tool, Diabetes Personal Health Decisions (PHD), allows users to enter health information such as age, weight, medication, and family history, to determine a health risk profile. After receiving the results, users can adjust lifestyle factors, such as taking low doses of aspirin or losing weight, to see how making these changes affect their health and risk factors, according to the Web site. Users can also print or e-mail their results to share with their doctors. Diabetes PHD uses Archimedes software, which was developed by Kaiser Permanente with support from Bristol-Myers Squibb, to calculate health variables, resulting in what the American Diabetes Association says is the most accurate health risk-profiling tool ever developed. The tool is funded through the American Diabetes Association's Doing Better: Tools for Diabetes Care initiative, which is funded by companies such as AstraZeneca, Novo Nordisk, and Sanofi-Aventis.

 

https://www.diabetes.org/phd/profile/default.jsp